ResMed reports increased income, revenue
SAN DIEGO – ResMed reported net income of $80.9 million for the quarter ended Sept. 30 compared to $71.3 million for the same period last year, a 14% increase.
Net revenue for the quarter was $357.7 million, up 5% from the same period last year.
Sales in the Americas were $201.5 million for the quarter, up 4% from the same period last year. Sales outside the Americas were $156.2 million, up 5%.
Operating profit for the quarter was $96.9 million, cash flow from operations was $90.4 million, and gross margin increased to 63.7%.
“We continued to face a tough competitive product cycle this quarter,” stated CEO Mick Farrell in a press release. “We have only just released our new mask products, but we were encouraged by their early sales. We have a rich pipeline of products scheduled for introduction over the course of this fiscal year, providing us with plenty of opportunities for robust growth ahead.”